728 related articles for article (PubMed ID: 29806680)
1. [Cardiotoxicity of anticancer therapies. Towards the implementation of cardio-oncology units].
Hameau R; Gabrielli L; Garrido M; Guzmán AM; Retamal I; Vacarezza MJ; Greig D; Ocqueteau M; Sánchez C; Pizarro M; Corvalán A; Lavandero S; Castro PF; Martínez G
Rev Med Chil; 2018 Jan; 146(1):68-77. PubMed ID: 29806680
[TBL] [Abstract][Full Text] [Related]
2. Organization and implementation of a cardio-oncology program.
Fiuza M; Ribeiro L; Magalhães A; Sousa AR; Nobre Menezes M; Jorge M; Costa L; Pinto FJ
Rev Port Cardiol; 2016 Sep; 35(9):485-94. PubMed ID: 27503589
[TBL] [Abstract][Full Text] [Related]
3. Canadian Cardiovascular Society Guidelines for Evaluation and Management of Cardiovascular Complications of Cancer Therapy.
Virani SA; Dent S; Brezden-Masley C; Clarke B; Davis MK; Jassal DS; Johnson C; Lemieux J; Paterson I; Sebag IA; Simmons C; Sulpher J; Thain K; Thavendiranathan P; Wentzell JR; Wurtele N; Côté MA; Fine NM; Haddad H; Hayley BD; Hopkins S; Joy AA; Rayson D; Stadnick E; Straatman L
Can J Cardiol; 2016 Jul; 32(7):831-41. PubMed ID: 27343741
[TBL] [Abstract][Full Text] [Related]
4. Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management.
Curigliano G; Cardinale D; Dent S; Criscitiello C; Aseyev O; Lenihan D; Cipolla CM
CA Cancer J Clin; 2016 Jul; 66(4):309-25. PubMed ID: 26919165
[TBL] [Abstract][Full Text] [Related]
5. Cardio-oncology: a multidisciplinary approach for detection, prevention and management of cardiac dysfunction in cancer patients.
Tajiri K; Aonuma K; Sekine I
Jpn J Clin Oncol; 2017 Aug; 47(8):678-682. PubMed ID: 28505345
[TBL] [Abstract][Full Text] [Related]
6. Common Cardiovascular Complications of Cancer Therapy: Epidemiology, Risk Prediction, and Prevention.
Narayan V; Ky B
Annu Rev Med; 2018 Jan; 69():97-111. PubMed ID: 29414258
[TBL] [Abstract][Full Text] [Related]
7. Concepts in cardio-oncology: definitions, mechanisms, diagnosis and treatment strategies of cancer therapy-induced cardiotoxicity.
Wickramasinghe CD; Nguyen KL; Watson KE; Vorobiof G; Yang EH
Future Oncol; 2016 Mar; 12(6):855-70. PubMed ID: 26829050
[TBL] [Abstract][Full Text] [Related]
8. Current and emerging modalities for detection of cardiotoxicity in cardio-oncology.
Khouri MG; Klein MR; Velazquez EJ; Jones LW
Future Cardiol; 2015 Jul; 11(4):471-84. PubMed ID: 26235924
[TBL] [Abstract][Full Text] [Related]
9. Cardio-oncology - strategies for management of cancer-therapy related cardiovascular disease.
Totzeck M; Schuler M; Stuschke M; Heusch G; Rassaf T
Int J Cardiol; 2019 Apr; 280():163-175. PubMed ID: 30661849
[TBL] [Abstract][Full Text] [Related]
10. Strategies to Prevent Cardiotoxicity.
Graffagnino J; Kondapalli L; Arora G; Hawi R; Lenneman CG
Curr Treat Options Oncol; 2020 Apr; 21(4):32. PubMed ID: 32270293
[TBL] [Abstract][Full Text] [Related]
11. Cardio-oncology: the new frontier of clinical and preventive cardiology.
Paris S; Tarantini L; Navazio A; Faggiano P
Monaldi Arch Chest Dis; 2020 Jun; 90(2):. PubMed ID: 32571000
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular Biomarkers in Cardio-Oncology: Antineoplastic Drug Cardiotoxicity and Beyond.
Attanasio U; Di Sarro E; Tricarico L; Di Lisi D; Armentaro G; Miceli S; Fioretti F; Deidda M; Correale M; Novo G; Sciacqua A; Nodari S; Cadeddu C; Tocchetti CG; Palazzuoli A; Mercurio V
Biomolecules; 2024 Feb; 14(2):. PubMed ID: 38397436
[TBL] [Abstract][Full Text] [Related]
13. Shared Risk Factors for Cardiovascular Disease and Cancer: Implications for Preventive Health and Clinical Care in Oncology Patients.
Johnson CB; Davis MK; Law A; Sulpher J
Can J Cardiol; 2016 Jul; 32(7):900-7. PubMed ID: 27343745
[TBL] [Abstract][Full Text] [Related]
14. Oncologic therapies associated with cardiac toxicities: how to minimize the risks.
Cardinale D; Stivala F; Cipolla CM
Expert Rev Anticancer Ther; 2019 May; 19(5):359-374. PubMed ID: 30916598
[TBL] [Abstract][Full Text] [Related]
15. [Cardiotoxicity relatively common in cancer treatment].
Bühlmann Lerjen E; Hübbert L; Papakonstantinou A; Hedayati E; Linde C; Månsson Broberg A
Lakartidningen; 2016 Jun; 113():. PubMed ID: 27299327
[TBL] [Abstract][Full Text] [Related]
16. Cardio-oncology: Gaps in Knowledge, Goals, Advances, and Educational Efforts.
Biasillo G; Cipolla CM; Cardinale D
Curr Oncol Rep; 2017 Aug; 19(8):55. PubMed ID: 28707189
[TBL] [Abstract][Full Text] [Related]
17. Non-coding RNAs, cancer treatment and cardiotoxicity: A triad of new hope.
Mittal R; Krishnan M P S; Saxena R; Sampath A; Goyal B
Cancer Treat Res Commun; 2023; 36():100750. PubMed ID: 37531735
[TBL] [Abstract][Full Text] [Related]
18. Cardio-oncology Part II: the monitoring, prevention, detection and treatment of chemotherapeutic cardiac toxicity.
O'Hare M; Murphy K; Mookadam F; Sharma A; Lee H
Expert Rev Cardiovasc Ther; 2015 May; 13(5):519-27. PubMed ID: 25864865
[TBL] [Abstract][Full Text] [Related]
19. [The Cardio-Oncology Guideline - A Comprehensive Approach to Managing Cardiovascular Risks in Cancer Patients].
Romann SW; Frey N; Lehmann L
Dtsch Med Wochenschr; 2024 Jun; 149(12):719-723. PubMed ID: 38781996
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular Toxicities in Pediatric Cancer Survivors.
Ryan TD; Nagarajan R; Godown J
Cardiol Clin; 2019 Nov; 37(4):533-544. PubMed ID: 31587793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]